Medicinal cannabis products that meet the minimum quality standard

19 May 2022:  New medicinal cannabis products have been verified as meeting the minimum quality standard  – Read more.

Generally, medicinal cannabis products are only available, on prescription, if they have:

  • been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or
  • obtained consent for distribution under the Medicines Act 1981 (approved and provisionally approved medicines)

Any doctor can prescribe a product listed here. A specialist recommendation and Ministerial approval are not required. For more information on a particular product, please contact the listed product supplier or manufacturer.

Medicinal cannabis products that meet the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019

Products that are listed as having been verified as meeting the minimum quality standards are unapproved medicines – there has been no assessment of their safety or efficacy. Being listed here does not guarantee that these products are currently available in New Zealand. Contact the licence holder to obtain the most up-to-date information on product availability.

Dosage Products - Prescription Medicine

The products listed in the following tables are categorised by their verified dosage form.  The products have been verified as meeting the testing requirements and microbiological contamination limits applicable to the dosage form as listed.

Oral Liquids

Product Name

Active Ingredients

Pack Sizes (mL)

Administration notes

Licence holder

RUA CBD100

Total CBD (CBD+CBDA) 100 mg/mL

30

Oral, 1mL oral syringe with 0.05 mL volume markings

RUA Bioscience Limited

Tilray P Oral Solution CBD 100

Total CBD (CBD+CBDA) 106.4 mg/g (100 mg/mL)

25, 40

Oral, 1 mL dropper with volume markings

CDC Pharmaceuticals Ltd

Tilray P Oral Solution CBD 25

Total CBD (CBD+CBDA) 26.6 mg/g (25 mg/mL)

 

40

Oral, 1 mL dropper with volume markings

CDC Pharmaceuticals Ltd

Sublingual Solutions

Product Name

Active Ingredients

Pack Sizes (mL)

Administration notes

Licence holder

SubDrops™ CBD100

Total CBD (CBD+CBDA) 100 mg/mL

30

Sublingual, 1 mL dropper with 0.25 mL volume markings

Helius Therapeutics Limited

SubDrops™ CBD25

Total CBD (CBD+CBDA) 25 mg/mL

30

Sublingual, 1 mL dropper with 0.25 mL volume markings

Helius Therapeutics Limited

Dosage Products - Controlled Drug B1

Oral Liquids

Product Name

Active Ingredients

Pack Sizes (mL)

Administration notes

Licence holder

evalaCann THC ≤1 mg: CBD 20 mg

Total THC (THC+THCA) ≤1 mg

Total CBD (CBD+CBDA) 20 mg

30 Oral, 1 mL or 1.5 mL oral; syringe with 0.1 mL volume markings Cannasouth Bioscience Ltd
evalaCann THC 10 mg: CBD 15 mg

Total THC (THC+THCA) 10 mg

Total CBD (CBD+CBDA) 15 mg

30 Oral, 1 mL or 1.5 mL oral; syringe with 0.1 mL volume markings Cannasouth Bioscience Ltd
evalaCann THC 10 mg: CBD  ≤1 mg

Total THC (THC+THCA) 10 mg

Total CBD (CBD+CBDA) ≤1 mg

30 Oral, 1 mL or 1.5 mL oral; syringe with 0.1 mL volume markings Cannasouth Bioscience Ltd

Tilray FS oral Solution THC 25

Total THC (THC+THCA) 26.6 mg / g (25 mg/ mL)

40

Oral, 1 mL dropper with volume markings

CDC Pharmaceuticals Ltd

Tilray FS Oral Solution THC 10 CBD 10

Total THC (THC+THCA) 10.5 mg/g (10 mg/mL)

Total CBD  (CBD+CBDA) 10.5 mg/g (10 mg/mL)

40

Oral, 1 mL oral syringe with 0.1 mL volume markings

CDC Pharmaceuticals Ltd

Dried Products- Controlled Drug C1

The products listed in the following tables are categorised by their verified administration route.  The products have been verified as meeting the microbiological contamination limits for the administration route as listed.

Dried cannabis flower for inhalation via a vaporiser

Product Name

Active Ingredients

Pack Sizes (g)

Administration notes

Licence holder

KIKUYA Dune

Total THC (THC+THCA) 190 mg/g (19% w/w)

 

Total CBD (CBD+CBDA) ≤10 mg/g (≤1%w/w)

10

Inhalation via vaporiser

MW Pharma Limited t/a NUBU Pharmaceuticals

Dried cannabis flower for preparation of tea for oral consumption

Note: This product does not meet the minimum quality standard for inhalation

Product Name

Active Ingredients

Pack Sizes (g)

Administration notes

Licence holder

ANTG Eve

Total THC (THC+THCA) 10 mg/g (˂ 1% w/w)

Total CBD (CBD+CBDA) 125 mg/g (12.5% w/w)

10

Tea preparation for oral consumption.
View tea preparation instructions.

 

MW Pharma Limited t/a NUBU Pharmaceuticals

ANTG Mariposa

Total THC (THC+THCA) 135 mg/g (13.5% w/w)

Total CBD (CBD+CBDA) <10 mg/g (<1% w/w)

10

Tea preparation for oral consumption.
View tea preparation instructions

 

MW Pharma Limited t/a NUBU Pharmaceuticals

ANTG Rocky

Total THC (THC+THCA) 250 mg/g (25% w/w)

Total CBD (CBD+CBDA) <10 mg/g (<1% w/w)

10

Tea preparation for oral consumption.
View tea preparation instructions

 

MW Pharma Limited t/a NUBU Pharmaceuticals

ANTG Solace

Total THC (THC+THCA): 200 mg/g (20% w/w)

Total CBD (CBD+CBDA): <10 mg/g (<1% w/w)

10

Tea preparation for oral consumption.
View tea preparation instructions

MW Pharma Limited t/a NUBU Pharmaceuticals

Medium THC Wholeflower Shishkaberry

Total THC (THC+THCA): 152.5 mg/g (15.25% w/w)

Total CBD (CBD+CBDA): <5 mg/g (<0.5% w/w)

35 Tea preparation for oral consumption.
View tea preparation instructions
 
JC logistics t/a Medleaf Therapeutics

Products with consent for distribution (approved and provisionally approved) under the Medicines Act 1981

Approved and provisionally approved medicines have been assessed by Medsafe and have demonstrated that they meet New Zealand and internationally recognised standards for quality, safety and efficacy. Approved and provisionally approved medicines are not required to be assessed against the minimum quality standard.

Product Name

Active Ingredients

Dose Form

Prescribing information

Information for consumers

Sponsor

Sativex oral spray

CBD 25 mg/mL equivalent to Cannabis sativa extract 35 mg–42 mg
THC 27 mg/mL equivalent to Cannabis sativa extract 38 mg–44 mg

Oromucosal spray

Sativex data sheet

Sativex consumer medicine information

Emerge Health New Zealand Limited
 


Tea preparation instructions for ANTG Eve, ANTG Mariposa, ANTG Rocky, ANTG Solace and Shishkaberry

  1. Bring 500 ml (0.5 litres) of water to the boil in a covered vessel
  2. Granulate product (using a grinder is easiest) into fine pieces
  3. Add 0.5 gram of product to vessel
  4. Turn down the heat and simmer the tea for 15 minutes with the lid on the vessel
  5. Remove the covered vessel from the heat and strain the tea
  6. Store the leftover tea in a thermos if you are to drink more of it on the same day

After preparation - as described above - add a sachet of coffee creamer powder to the warm tea. This prevents the active ingredients in the tea from sticking to the inside of the teapot or mug after cooling.

Return to approved products

Back to top